Post-acute COVID-19 syndrome. Incidence and risk factors : A Mediterranean cohort study
Copyright © 2021. Published by Elsevier Ltd..
OBJECTIVES: This study aims to analyze the incidence of Post-acute COVID-19 syndrome (PCS) and its components, and to evaluate the acute infection phase associated risk factors.
METHODS: A prospective cohort study of adult patients who had recovered from COVID-19 (27th February to 29th April 2020) confirmed by PCR or subsequent seroconversion, with a systematic assessment 10-14 weeks after disease onset. PCS was defined as the persistence of at least one clinically relevant symptom, or abnormalities in spirometry or chest radiology. Outcome predictors were analyzed by multiple logistic regression (OR; 95%CI).
RESULTS: Two hundred seventy seven patients recovered from mild (34.3%) or severe (65.7%) forms of SARS-CoV-2 infection were evaluated 77 days (IQR 72-85) after disease onset. PCS was detected in 141 patients (50.9%; 95%CI 45.0-56.7%). Symptoms were mostly mild. Alterations in spirometry were noted in 25/269 (9.3%), while in radiographs in 51/277 (18.9%). No baseline clinical features behaved as independent predictors of PCS development.
CONCLUSIONS: A Post-acute COVID-19 syndrome was detected in a half of COVID19 survivors. Radiological and spirometric changes were mild and observed in less than 25% of patients. No baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development.
| Errataetall: |
CommentIn: J Infect. 2021 Jun;82(6):e11-e13. - PMID 33826926 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
The Journal of infection - 82(2021), 3 vom: 01. März, Seite 378-383 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Moreno-Pérez, Oscar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Associated factors |
|---|
| Anmerkungen: |
Date Completed 24.03.2021 Date Revised 10.11.2023 published: Print-Electronic CommentIn: J Infect. 2021 Jun;82(6):e11-e13. - PMID 33826926 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jinf.2021.01.004 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320134881 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320134881 | ||
| 003 | DE-627 | ||
| 005 | 20231225172932.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jinf.2021.01.004 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1067.xml |
| 035 | |a (DE-627)NLM320134881 | ||
| 035 | |a (NLM)33450302 | ||
| 035 | |a (PII)S0163-4453(21)00009-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Moreno-Pérez, Oscar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Post-acute COVID-19 syndrome. Incidence and risk factors |b A Mediterranean cohort study |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 24.03.2021 | ||
| 500 | |a Date Revised 10.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: J Infect. 2021 Jun;82(6):e11-e13. - PMID 33826926 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021. Published by Elsevier Ltd. | ||
| 520 | |a OBJECTIVES: This study aims to analyze the incidence of Post-acute COVID-19 syndrome (PCS) and its components, and to evaluate the acute infection phase associated risk factors | ||
| 520 | |a METHODS: A prospective cohort study of adult patients who had recovered from COVID-19 (27th February to 29th April 2020) confirmed by PCR or subsequent seroconversion, with a systematic assessment 10-14 weeks after disease onset. PCS was defined as the persistence of at least one clinically relevant symptom, or abnormalities in spirometry or chest radiology. Outcome predictors were analyzed by multiple logistic regression (OR; 95%CI) | ||
| 520 | |a RESULTS: Two hundred seventy seven patients recovered from mild (34.3%) or severe (65.7%) forms of SARS-CoV-2 infection were evaluated 77 days (IQR 72-85) after disease onset. PCS was detected in 141 patients (50.9%; 95%CI 45.0-56.7%). Symptoms were mostly mild. Alterations in spirometry were noted in 25/269 (9.3%), while in radiographs in 51/277 (18.9%). No baseline clinical features behaved as independent predictors of PCS development | ||
| 520 | |a CONCLUSIONS: A Post-acute COVID-19 syndrome was detected in a half of COVID19 survivors. Radiological and spirometric changes were mild and observed in less than 25% of patients. No baseline clinical features behaved as independent predictors of Post-acute COVID-19 syndrome development | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Associated factors | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cohort study | |
| 650 | 4 | |a Diagnostic imaging | |
| 650 | 4 | |a Health-related quality of life | |
| 650 | 4 | |a Life quality | |
| 650 | 4 | |a Sequelae | |
| 650 | 4 | |a Spirometry | |
| 650 | 4 | |a Symptoms | |
| 650 | 4 | |a Syndrome | |
| 700 | 1 | |a Merino, Esperanza |e verfasserin |4 aut | |
| 700 | 1 | |a Leon-Ramirez, Jose-Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Andres, Mariano |e verfasserin |4 aut | |
| 700 | 1 | |a Ramos, Jose Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Arenas-Jiménez, Juan |e verfasserin |4 aut | |
| 700 | 1 | |a Asensio, Santos |e verfasserin |4 aut | |
| 700 | 1 | |a Sanchez, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Ruiz-Torregrosa, Paloma |e verfasserin |4 aut | |
| 700 | 1 | |a Galan, Irene |e verfasserin |4 aut | |
| 700 | 1 | |a Scholz, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Amo, Antonio |e verfasserin |4 aut | |
| 700 | 1 | |a González-delaAleja, Pilar |e verfasserin |4 aut | |
| 700 | 1 | |a Boix, Vicente |e verfasserin |4 aut | |
| 700 | 1 | |a Gil, Joan |e verfasserin |4 aut | |
| 700 | 0 | |a COVID19-ALC research group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 82(2021), 3 vom: 01. März, Seite 378-383 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2021 |g number:3 |g day:01 |g month:03 |g pages:378-383 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2021.01.004 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2021 |e 3 |b 01 |c 03 |h 378-383 | ||